~~<i id='782318A153'><strike id='782318A153'><tt id='782318A153'><pre id='782318A153'></pre></tt></strike></i>~~

Home» Wikipedia» explore

explore

author：knowledge 2025-09-27 13:49:26 Page View：51

Neumora, a neuroscience startup founded by VC Arch Venture Partners, hopes to become one of the few biotechs to go public this year.

The company filed paperwork for an IPO with the Securities and Exchange Commission on Friday. It did not state how many shares it plans to sell or at what price.

The biotech had begun planning for an IPO last year, STAT reported in June 2022. It raised $112 million in what would turn out to be a crossover round last October.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： In surprise move, FDA calls for advisory committee on Lilly's Alzheimer's drug
Next article： 23andMe had bad news about my health. I wish a person had delivered it

comprehensive

Supreme Court strikes down use of affirmative action

ActivistsdemonstratedastheSupremeCourtheardoralargumentsonapairofaffirmativeactioncasesinOctober2022

Australia's humpback populations rebound raising hopes of marine scientists

0:50AhumpbackwhalebreachesnearSydney,Australia,June24,2023.CourtesyMarkWongJulymarksthepeakofthehump

The high cost of giving birth even with insurance

AdobeTheburdenofhighhealthcarecostsandmedicaldebtintheU.S.isnosecret.Medicaldebtaffectsoneinfiveadul

Meta looks to target Twitter with a rival app called Threads

Theannouncementofthesocialmediaapp'Threads'isdisplayedinApple'sUSAppStoreseenonthescreenofasmartphon